|

OL-108 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Beijing GoBroad Hospital1

Indications

  • Idiopathic Inflammatory Myopathy (IIM)1
  • ANCA Associated Vasculitis (AAV)1
  • Systemic Sclerosis (SSc)1
  • Systemic Lupus Erythematosus (SLE)1
  • Lupus1

Other1 trial

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.